Dr. Bruce Martin Ennis, MD

Dr. Ennis practices at Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery.

Dr. Ennis' NPI, 1639134901, was assigned on April 19, 2006. Dr. Ennis graduated from Universidad Autonoma de Guadalajara in 1983. Dr. Ennis' Louisiana license number on file is 201758.

Dr. Ennis' primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery, at 8100 South Walker Bldg C, Oklahoma City, OK 73139 in Oklahoma County. The practice phone is (405) 602-6500.

Dr. Ennis' primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery. Dr. Ennis is also affiliated with North Oaks Medical Center. The medical group on file is North Oaks Medical Center. Dmand AI also links Dr. Ennis to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ennis practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Ennis' primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Ennis is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ennis' licenses on file in 4 states: Louisiana, Texas, Florida and Illinois.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, chronic hypertension and coronary artery disease among the conditions Dr. Ennis treats.

CMS data shows 3,695 Medicare services from Dr. Ennis across 29 procedure codes in 2024, for 1,118 Medicare patients. Medicare paid $137,542 for them.

CMS counts 1,118 Medicare patients who saw Dr. Ennis in 2024. The largest group is 65 to 74, with 459 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ennis' median patient age at 65, with 54% women.

In 2024, Dr. Ennis wrote 5,496 Medicare Part D claims for 625 patients. 84% of them were for generic drugs. CMS names the drug for 5,256 of them, across 57 drugs with 11 or more claims each, at $600,020 in total drug cost. In 2023, CMS named 5,437 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Ennis for performance year 2024, reported as part of a group. Dr. Ennis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of coronary angioplasty and stenting by Dr. Ennis, more than 40% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Ennis. Dr. Ennis' most frequent co-authors are Lloyd W. Klein, MD and David M. Zientek, MD.

CMS Open Payments shows 1,023 general payments to Dr. Ennis from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Medtronic, Inc. paid the most, $15,162.

Dmand AI lists 1 award for Dr. Ennis, most recently CMS Stage 1 EHR in 2012.

Dr. Ennis graduated from Universidad Autonoma de Guadalajara in 1983.

Dr. Ennis is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.